• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPARα/γ在小鼠和人类黑素细胞及黑色素瘤细胞中的表达与活性

PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells.

作者信息

Eastham Linda L, Mills Caroline N, Niles Richard M

机构信息

Department of Biochemistry and Microbiology, Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia 25755, USA.

出版信息

Pharm Res. 2008 Jun;25(6):1327-33. doi: 10.1007/s11095-007-9524-9.

DOI:10.1007/s11095-007-9524-9
PMID:18172578
Abstract

PURPOSE

We examined the expression of PPARs and the effects of PPARalpha and PPARgamma agonists on growth of mouse and human melanocytes and melanoma cells.

METHODS

PPARalpha,beta, and PPARgamma mRNA qualitative expression in melan-a mouse melanocytes, B16 mouse melanoma, human melanocytes, and A375 and SK-mel28 human melanoma cells was determined by RT-PCR, while quantitative PPARalpha mRNA levels were determined by QuantiGene assay. PPARalpha and PPARgamma protein was assessed by Western blotting. The effect of natural and synthetic PPAR ligands on cell growth was determined by either hemocytometer counting or crystal violet assay. PPAR transcriptional activity was determined by a PPRE-reporter gene assay, while knockdown of PPARalpha expression was achieved by transient transfection of siRNA.

RESULTS

Both mouse and human melanoma cells produced more PPARalpha and PPARgamma protein compared to melanocytes. PPARalpha mRNA levels were elevated in human melanoma cells, but not in mouse melanoma cells relative to melanocytes. Silencing of PPARalpha in human melanoma cells did not alter cell proliferation or morphology. PPARgamma-selective agonists inhibited the growth of both mouse and human melanoma cells, while PPARalpha-selective agonists had limited effects.

CONCLUSION

Increased expression of PPARalpha in melanoma relative to melanocytes may be a common occurrence, however its biologic significance remains to be determined. PPARgamma agonists may be useful for arresting the growth of some melanomas.

摘要

目的

我们研究了过氧化物酶体增殖物激活受体(PPARs)的表达以及PPARα和PPARγ激动剂对小鼠和人类黑素细胞及黑色素瘤细胞生长的影响。

方法

通过逆转录聚合酶链反应(RT-PCR)测定黑素-a小鼠黑素细胞、B16小鼠黑色素瘤、人类黑素细胞以及A375和SK-mel28人类黑色素瘤细胞中PPARα、β和PPARγ mRNA的定性表达,同时通过QuantiGene检测法定量测定PPARα mRNA水平。通过蛋白质免疫印迹法评估PPARα和PPARγ蛋白。通过血细胞计数器计数或结晶紫测定法确定天然和合成的PPAR配体对细胞生长的影响。通过PPRE报告基因测定法确定PPAR转录活性,同时通过小干扰RNA(siRNA)的瞬时转染实现PPARα表达的敲低。

结果

与黑素细胞相比,小鼠和人类黑色素瘤细胞产生更多的PPARα和PPARγ蛋白。相对于黑素细胞,人类黑色素瘤细胞中PPARα mRNA水平升高,但小鼠黑色素瘤细胞中未升高。在人类黑色素瘤细胞中沉默PPARα不会改变细胞增殖或形态。PPARγ选择性激动剂抑制小鼠和人类黑色素瘤细胞的生长,而PPARα选择性激动剂的作用有限。

结论

相对于黑素细胞,黑色素瘤中PPARα表达增加可能是常见现象,但其生物学意义仍有待确定。PPARγ激动剂可能有助于阻止某些黑色素瘤的生长。

相似文献

1
PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells.PPARα/γ在小鼠和人类黑素细胞及黑色素瘤细胞中的表达与活性
Pharm Res. 2008 Jun;25(6):1327-33. doi: 10.1007/s11095-007-9524-9.
2
The α-melanocyte stimulating hormone/peroxisome proliferator activated receptor-γ pathway down-regulates proliferation in melanoma cell lines.α-黑素细胞刺激激素/过氧化物酶体增殖物激活受体-γ 通路下调黑素瘤细胞系的增殖。
J Exp Clin Cancer Res. 2017 Oct 11;36(1):142. doi: 10.1186/s13046-017-0611-4.
3
The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.转录共激活因子过氧化物酶体增殖物激活受体(PPAR)γ共激活因子-1α和核受体PPARα在人白色脂肪细胞中独立于PPARγ激活来控制甘油激酶和代谢基因的表达。
Diabetes. 2007 Oct;56(10):2467-75. doi: 10.2337/db06-1465. Epub 2007 Jul 23.
4
Regulation of peroxisome proliferator-activated receptors (PPAR) α and -γ of rat brain astrocytes in the course of activation by toll-like receptor agonists.Toll样受体激动剂激活过程中大鼠脑星形胶质细胞过氧化物酶体增殖物激活受体(PPAR)α和-γ的调节
J Neurochem. 2015 Jul;134(1):113-24. doi: 10.1111/jnc.13101. Epub 2015 Apr 16.
5
Peroxisome proliferator-activated receptor α (PPARα) contributes to control of melanogenesis in B16 F10 melanoma cells.过氧化物酶体增殖物激活受体α(PPARα)有助于调控B16 F10黑色素瘤细胞中的黑色素生成。
Arch Dermatol Res. 2017 Apr;309(3):141-157. doi: 10.1007/s00403-016-1711-2. Epub 2017 Jan 13.
6
Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.全氟辛酸和全氟辛烷磺酸对小鼠和人类过氧化物酶体增殖物激活受体(α、β/δ、γ)的激活作用。
Toxicol Sci. 2007 Jan;95(1):108-17. doi: 10.1093/toxsci/kfl135. Epub 2006 Oct 17.
7
PPAR Agonists: I. Role of Receptor Subunits in Alcohol Consumption in Male and Female Mice.过氧化物酶体增殖物激活受体激动剂:I. 受体亚基在雄性和雌性小鼠酒精摄入中的作用
Alcohol Clin Exp Res. 2016 Mar;40(3):553-62. doi: 10.1111/acer.12976. Epub 2016 Feb 9.
8
Megalin/LRP2 expression is induced by peroxisome proliferator-activated receptor -alpha and -gamma: implications for PPARs' roles in renal function.巨胞饮受体/LRP2 的表达受过氧化物酶体增殖物激活受体-α和 -γ诱导:提示 PPARs 在肾功能中的作用。
PLoS One. 2011 Feb 2;6(2):e16794. doi: 10.1371/journal.pone.0016794.
9
Inhibition of adult liver progenitor (oval) cell growth and viability by an agonist of the peroxisome proliferator activated receptor (PPAR) family member gamma, but not alpha or delta.过氧化物酶体增殖物激活受体(PPAR)家族成员γ的激动剂可抑制成年肝祖细胞(卵圆细胞)的生长和活力,而α或δ的激动剂则无此作用。
Carcinogenesis. 2005 Oct;26(10):1782-92. doi: 10.1093/carcin/bgi138. Epub 2005 May 25.
10
Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.过氧化物酶体增殖物激活受体α(PPARα)、过氧化物酶体增殖物激活受体δ(PPARδ)和过氧化物酶体增殖物激活受体γ(PPARγ)报告基因细胞系对选择性PPAR合成配体的不同反应。
Anal Biochem. 2005 Sep 1;344(1):8-15. doi: 10.1016/j.ab.2005.06.010.

引用本文的文献

1
PPAR-γ in Melanoma and Immune Cells: Insights into Disease Pathogenesis and Therapeutic Implications.黑色素瘤与免疫细胞中的过氧化物酶体增殖物激活受体γ:对疾病发病机制及治疗意义的见解
Cells. 2025 Apr 2;14(7):534. doi: 10.3390/cells14070534.
2
Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds.发现不直接与受体结合的过氧化物酶体增殖物激活受体α脂质途径调节剂作为潜在的抗癌化合物。
Int J Mol Sci. 2025 Jan 16;26(2):736. doi: 10.3390/ijms26020736.
3
PPARs and the Kynurenine Pathway in Melanoma-Potential Biological Interactions.

本文引用的文献

1
PPAR-gamma agonist, ciglitazone, increases pigmentation and migration of human melanocytes.过氧化物酶体增殖物激活受体γ激动剂环格列酮可增加人类黑素细胞的色素沉着和迁移。
Exp Dermatol. 2007 Feb;16(2):118-23. doi: 10.1111/j.1600-0625.2006.00521.x.
2
Dual PPARalpha/gamma ligand TZD18 either alone or in combination with imatinib inhibits proliferation and induces apoptosis of human CML cell lines.双重PPARα/γ配体TZD18单独或与伊马替尼联合使用时,可抑制人慢性粒细胞白血病细胞系的增殖并诱导其凋亡。
Cell Cycle. 2006 Oct;5(19):2237-43. doi: 10.4161/cc.5.19.3259. Epub 2006 Oct 1.
3
Growth inhibition and differentiation induced by peroxisome proliferator activated receptor gamma ligand rosiglitazone in human melanoma cell line A375.
过氧化物酶体增殖物激活受体与黑色素瘤中的犬尿氨酸途径:潜在的生物学相互作用。
Int J Mol Sci. 2023 Feb 4;24(4):3114. doi: 10.3390/ijms24043114.
4
Accelerated Barrier Repair in Human Skin Explants Induced with a Plant-Derived PPAR-α Activating Complex via Cooperative Interactions.通过协同相互作用,植物来源的PPAR-α激活复合物诱导人皮肤外植体中的加速屏障修复。
Clin Cosmet Investig Dermatol. 2021 Sep 18;14:1271-1293. doi: 10.2147/CCID.S325967. eCollection 2021.
5
Activation of PPARγ Inhibits TLR4 Signal Transduction Pathway in Melanoma Cancer .过氧化物酶体增殖物激活受体γ(PPARγ)的激活抑制黑色素瘤中的Toll样受体4(TLR4)信号转导通路 。
Adv Pharm Bull. 2020 Jul;10(3):458-463. doi: 10.34172/apb.2020.056. Epub 2020 May 11.
6
Standardized Pericarp Extract, Suppresses Tumor Proliferation and Angiogenesis in a Mouse Model of Melanoma: Possible Involvement of PPARα and PPARγ Pathways.标准化果皮提取物抑制黑色素瘤小鼠模型中的肿瘤增殖和血管生成:PPARα和PPARγ途径可能参与其中。
Iran J Pharm Res. 2019 Winter;18(1):348-357.
7
Editor's Highlight: PPARβ/δ and PPARγ Inhibit Melanoma Tumorigenicity by Modulating Inflammation and Apoptosis.编辑精选:PPARβ/δ 和 PPARγ 通过调节炎症和细胞凋亡抑制黑色素瘤的肿瘤发生。
Toxicol Sci. 2017 Oct 1;159(2):436-448. doi: 10.1093/toxsci/kfx147.
8
Correlation between microtubule-associated gene expression and chemosensitivity of patients with stage II non-small cell lung cancer.II期非小细胞肺癌患者微管相关基因表达与化疗敏感性的相关性
Exp Ther Med. 2013 May;5(5):1506-1510. doi: 10.3892/etm.2013.1007. Epub 2013 Mar 14.
9
Low expression of stathmin in tumor predicts high response to neoadjuvant chemotherapy with docetaxel-containing regimens in locally advanced breast cancer.在局部晚期乳腺癌中,肿瘤中Stathmin低表达预示着对含多西他赛方案的新辅助化疗有高反应性。
Genet Test Mol Biomarkers. 2012 Jul;16(7):689-94. doi: 10.1089/gtmb.2011.0298. Epub 2012 Apr 5.
10
Activation of vitamin D receptor (VDR)- and peroxisome proliferator-activated receptor (PPAR)-signaling pathways through 1,25(OH)(2)D(3) in melanoma cell lines and other skin-derived cell lines.通过1,25(OH)₂D₃在黑色素瘤细胞系和其他皮肤来源细胞系中激活维生素D受体(VDR)和过氧化物酶体增殖物激活受体(PPAR)信号通路。
Dermatoendocrinol. 2009 Jul;1(4):232-8. doi: 10.4161/derm.1.4.9629.
过氧化物酶体增殖物激活受体γ配体罗格列酮诱导人黑素瘤细胞系 A375 的生长抑制和分化。
Med Oncol. 2006;23(3):393-402. doi: 10.1385/mo:23:3:393.
4
Anti-proliferative effect of peroxisome proliferator-activated receptor gamma agonists on human malignant melanoma cells in vitro.过氧化物酶体增殖物激活受体γ激动剂对人恶性黑色素瘤细胞的体外抗增殖作用。
Anticancer Drugs. 2006 Mar;17(3):325-32. doi: 10.1097/00001813-200603000-00011.
5
PPARgamma-independent induction of growth arrest and apoptosis in prostate and bladder carcinoma.前列腺癌和膀胱癌中不依赖过氧化物酶体增殖物激活受体γ的生长停滞和凋亡诱导
BMC Cancer. 2006 Mar 6;6:53. doi: 10.1186/1471-2407-6-53.
6
Isoform specific changes in PPAR alpha and beta in colon and breast cancer with differentiation.结肠和乳腺癌中PPARα和β随分化的亚型特异性变化。
Biochem Biophys Res Commun. 2006 Feb 10;340(2):656-60. doi: 10.1016/j.bbrc.2005.12.061. Epub 2005 Dec 20.
7
Differential responses of PPARalpha, PPARdelta, and PPARgamma reporter cell lines to selective PPAR synthetic ligands.过氧化物酶体增殖物激活受体α(PPARα)、过氧化物酶体增殖物激活受体δ(PPARδ)和过氧化物酶体增殖物激活受体γ(PPARγ)报告基因细胞系对选择性PPAR合成配体的不同反应。
Anal Biochem. 2005 Sep 1;344(1):8-15. doi: 10.1016/j.ab.2005.06.010.
8
Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing.角质形成细胞中过氧化物酶体增殖物激活受体显性负性形式的选择性表达导致表皮愈合受损。
Mol Endocrinol. 2005 Sep;19(9):2335-48. doi: 10.1210/me.2005-0068. Epub 2005 May 12.
9
The effect of PPARgamma ligands on UV- or chemically-induced carcinogenesis in mouse skin.过氧化物酶体增殖物激活受体γ(PPARγ)配体对小鼠皮肤紫外线或化学诱导致癌作用的影响。
Mol Carcinog. 2005 Aug;43(4):198-206. doi: 10.1002/mc.20111.
10
Peroxisome proliferator-activated receptors in squamous cell carcinoma and its precursors.过氧化物酶体增殖物激活受体在鳞状细胞癌及其前驱病变中的作用
J Cutan Pathol. 2005 May;32(5):340-7. doi: 10.1111/j.0303-6987.2005.00345.x.